Influx Healthtech Limited

Influx Healthtech Limited (INFLUX) is a micro-cap Healthcare company valued at ₹608 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move

Influx Healthtech Limited last traded at ₹264.1, down 3.22% on the day.

Recent developments

On 2026-03-31, the company reported its latest financial results, showing continued growth in both revenue and net profit. The company has maintained a debt-free balance sheet with debt to equity at 0.00. Promoter holding remained at 73.53%, with no significant changes in foreign or domestic institutional holdings.

Financial performance

The company's business is improving, with annual revenue rising 39.8% and annual net profit growing 58.0%. The latest quarter saw revenue and net profit both rise 40.4% and 37.5% respectively compared to the same quarter a year earlier. Net profit margin widened by 1.6 percentage points to 14.0%, while return on equity and return on capital employed remained strong at 20.4% and 27.2%.

Valuation multiples

The stock trades at 28.3 times earnings, broadly in line with the Healthcare median of 32.0, 6.48 times book value.

Things to watch

The company has not paid any dividends despite reporting repeated profits, which may raise concerns about capital returns to shareholders. The stock is currently 18.7% below its 52-week high, indicating a significant pullback from recent peak levels. The company's market cap of ₹593 crore places it in the micro-cap category, which can be more volatile.

Where it stands

Influx Healthtech Limited has delivered strong growth in both revenue and net profit over the past year and quarter, with margins and returns remaining robust. The company remains debt-free and is majority-owned by promoters, but its stock is trading below its 52-week high. The most significant figure is the 18.7% drop from its recent peak.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.